VC deal makes 16 times cost
3i and SEB Företagsinvest are selling Swedish vaccine distributor SBL Vaccines to Dutch biotechnology company Crucell for €39.4 million, generating an approximate 16 times return of the vendors’ investment.
11 January 2013•2 mins read
